Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-56 |
filingDate |
2018-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09de3efe5c479530a6a3f235304cf5a2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31211bae2a262eb4cb629a99aef28862 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_253fc860c10d9b807c1da047174dfca6 |
publicationDate |
2020-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-3692053-A1 |
titleOfInvention |
Immunomodulators |
abstract |
The present invention relates to novel macrocyclic peptides that inhibit protein-protein PD-1 / PD-L1 and PD-L1 / CD80 interactions, and are thus useful for alleviating various diseases, including cancer and infectious diseases. |
priorityDate |
2017-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |